Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
104 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07837440 | Psychoeducation for Anxiety, Depression, Cognitive Avoidance, and Sense of Coherence in Women With Cancer | completed | N/A | 40 | Ardakan UniversityOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT00450788 | Esophageal Cancer in Northeastern Iran | completed | — | 50,045 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT06311851 |
| Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases |
| active not recruiting |
| Phase 1 / Phase 2 |
| 40 |
| Pardis Noor Medical Imaging and Cancer CenterOTHER |
| 1 |
| Sep 16, 2026 |
| clinicaltrials |
| NCT07709299 | Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection | not yet recruiting | Early Phase 1 | 6 | Royan InstituteOTHER_GOV | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07675070 | Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors | recruiting | — | 100 | NanoAlvandINDUSTRY | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07657728 | Group Positive Psychology-Based Program for Fear of Breast Cancer Recurrence | completed | N/A | 38 | Golestan University of Medical sciencesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07329868 | Comparison of ACT and CBSM for Caregivers in Cancer | completed | N/A | 66 | Ardakan UniversityOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07311057 | Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy | enrolling by invitation | Phase 3 | 20 | Daryoush Hamidi Alamdari, PhDOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07311070 | Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue | enrolling by invitation | Phase 3 | 20 | Daryoush Hamidi Alamdari, PhDOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07298564 | Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS) | recruiting | N/A | 84 | Behnood AbbasiOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06737406 | Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart | recruiting | N/A | 60 | Mazandaran University of Medical SciencesOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT07254221 | Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients(ROSUBREAST) | not yet recruiting | Phase 4 | 400 | Shiraz University of Medical SciencesOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT05269771 | MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 8 | Nov 5, 2025 | clinicaltrials |
| NCT07197320 | Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy | not yet recruiting | — | 80 | Golestan University of Medical sciencesOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT07139119 | Educational Intervention on Skin Cancer Protective Behaviors Among Female Healthcare Workers | completed | N/A | 160 | Ahvaz Jundishapur University of Medical SciencesOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT07014163 | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | recruiting | N/A | 10 | Espad PharmedINDUSTRY | 1 | Jun 10, 2025 | clinicaltrials |
| NCT05711992 | Rare Embryonal Tumors of the Central Nervous System: International Registry | recruiting | — | 300 | Immune Oncology Research InstituteOTHER | 9 | May 8, 2025 | clinicaltrials |
| NCT06555003 | DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases(CLEAR-DEBIRI) | recruiting | Phase 3 | 116 | Tehran University of Medical SciencesOTHER | 1 | Apr 23, 2025 | clinicaltrials |
| NCT06674265 | Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma | recruiting | Phase 1 | 10 | Marzieh EbrahimiINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06687681 | Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas | recruiting | Phase 2 | 40 | Marzieh EbrahimiINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06697444 | Risk Factors and Disorders Linked to Uterine Adenomyosis on MRI in Reproductive-Age Women | completed | — | 50 | Mashhad University of Medical SciencesOTHER | 1 | Nov 20, 2024 | clinicaltrials |
| NCT06642363 | The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome | recruiting | Phase 1 | 44 | Isfahan University of Medical SciencesOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06625372 | Comparison of Intralipid With SMOF Lipid Following HSCT | recruiting | N/A | 50 | Shahid Beheshti UniversityOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06635330 | Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL | recruiting | Phase 1 / Phase 2 | 5 | Kara Yakhteh Tajhiz Azma CompanyNETWORK | 1 | Oct 10, 2024 | clinicaltrials |
| NCT06631040 | Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL | not yet recruiting | Phase 1 / Phase 2 | 10 | Shahid Beheshti University of Medical SciencesOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT06536712 | Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection | unknown | Phase 1 | 20 | Tehran University of Medical SciencesOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT04957212 | Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer | completed | Phase 3 | 214 | CinnagenINDUSTRY | 1 | Jul 26, 2024 | clinicaltrials |
| NCT03425656 | Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer | completed | Phase 3 | 108 | AryoGen Pharmed Co.INDUSTRY | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06353698 | Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia | unknown | N/A | 40 | National Nutrition and Food Technology InstituteOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06242249 | Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma | unknown | Phase 1 / Phase 2 | 10 | Shahid Beheshti University of Medical SciencesOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT03225586 | Prospective Urban Rural Epidemiology Study(PURE) | recruiting | — | 200,000 | Population Health Research InstituteOTHER | 25 | Jan 31, 2024 | clinicaltrials |
| NCT06199024 | Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles | unknown | N/A | 80 | Royan InstituteOTHER_GOV | 1 | Jan 10, 2024 | clinicaltrials |
| NCT06021379 | AryoTrust® (Trastuzumab) Safety Study | completed | — | 597 | AryoGen Pharmed Co.INDUSTRY | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04672720 | L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles | completed | N/A | 110 | Royan InstituteOTHER_GOV | 1 | Jun 18, 2023 | clinicaltrials |
| NCT04975620 | Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions | completed | N/A | 114 | University of TehranOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT03391934 | Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer | unknown | Phase 3 | 234 | CinnagenINDUSTRY | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05798455 | Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Tabriz University of Medical SciencesOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT04600986 | Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome | completed | N/A | 70 | Royan InstituteOTHER_GOV | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05203029 | Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast Cancer | completed | N/A | 198 | Isfahan University of Medical SciencesOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT05189873 | GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes | completed | Phase 3 | 128 | Tehran University of Medical SciencesOTHER | 1 | Jan 13, 2022 | clinicaltrials |
| NCT05130710 | The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer | completed | — | 80 | Tehran University of Medical SciencesOTHER | 1 | Dec 23, 2021 | clinicaltrials |
| NCT05108012 | Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients | unknown | Phase 1 | 5 | Royan InstituteOTHER_GOV | 1 | Nov 22, 2021 | clinicaltrials |
| NCT05091775 | The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure | completed | Phase 1 / Phase 2 | 140 | Shiraz University of Medical SciencesOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT04831437 | Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer | recruiting | Phase 2 | 60 | Tehran University of Medical SciencesOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT03876145 | The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome | completed | N/A | 120 | Royan InstituteOTHER_GOV | 1 | Apr 20, 2021 | clinicaltrials |
| NCT01003483 | Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients | completed | Phase 2 | 80 | Yazd Research & Clinical Center for InfertilityOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04268563 | Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients | unknown | Phase 1 / Phase 2 | 80 | Shahid Beheshti University of Medical SciencesOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT04653493 | CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) | unknown | Phase 1 | 22 | Sabz BiomedicalsINDUSTRY | 1 | Mar 19, 2021 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials